Context Therapeutics, a biotechnology company dedicated to creating new medicines for cancer, fibrosis, and neurodegenerative disease, today announced that the company has entered into agreements with three research partners.
Details:
www.businesswire.com/news/home/20170817005060/en/Context-Therapeutics-Initiates-Collaborations-Leading-Research-Partners
Details:
www.businesswire.com/news/home/20170817005060/en/Context-Therapeutics-Initiates-Collaborations-Leading-Research-Partners
No comments:
Post a Comment